END-STAGE KIDNEY DISEASE
Clinical trials for END-STAGE KIDNEY DISEASE explained in plain language.
Never miss a new study
Get alerted when new END-STAGE KIDNEY DISEASE trials appear
Sign up with your email to follow new studies for END-STAGE KIDNEY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a custom dialysis schedule keep kidney patients out of the hospital?
Disease control Recruiting nowThis study tests whether a personalized, gradual start to dialysis (based on how much kidney function remains) is safer and better for quality of life than the standard one-size-fits-all approach. About 350 adults with new kidney failure will be randomly assigned to either the pe…
Matched conditions: END-STAGE KIDNEY DISEASE
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated May 01, 2026 19:30 UTC
-
Dialysis patients get a voice: new symptom tracker aims to ease suffering
Symptom relief Recruiting nowThis study tests whether having dialysis patients regularly report their symptoms on a tablet, with nurses and doctors following up, can reduce discomfort and improve quality of life. About 2,400 adults on hemodialysis at up to 36 U.S. clinics will take part. Half will use the ne…
Matched conditions: END-STAGE KIDNEY DISEASE
Phase: NA • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated May 01, 2026 19:27 UTC
-
Virtual reality fights loneliness for dialysis patients
Symptom relief Recruiting nowThis study tests whether using social virtual reality (VR) during dialysis sessions can reduce loneliness and other symptoms in people with end-stage kidney disease. Sixty participants will use VR glasses for 30-45 minutes during their dialysis, three times a week for four weeks.…
Matched conditions: END-STAGE KIDNEY DISEASE
Phase: NA • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated May 01, 2026 15:58 UTC
-
Kidney patients needed for drug study
Knowledge-focused Recruiting nowThis study looks at how the body processes a new drug called eloralintide in people with severe kidney disease or kidney failure compared to healthy people. About 28 adults will receive a single injection under the skin. The goal is to measure drug levels in the blood and how lon…
Matched conditions: END-STAGE KIDNEY DISEASE
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated Apr 28, 2026 13:02 UTC